These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 28600720)

  • 21. Direct thrombin inhibition during percutaneous coronary intervention in patients with heparin-induced thrombocytopenia.
    Lewis BE; Hursting MJ
    Expert Rev Cardiovasc Ther; 2007 Jan; 5(1):57-68. PubMed ID: 17187457
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of a standardized protocol using lepirudin or argatroban for heparin-induced thrombocytopenia.
    Kennedy K; Steinke D; King S; Poe K; Reeves J; Short M
    Cardiovasc Hematol Agents Med Chem; 2011 Oct; 9(4):262-8. PubMed ID: 21902659
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Argatroban, bivalirudin, and lepirudin do not decrease clot propagation and strength as effectively as heparin-activated antithrombin in vitro.
    Nielsen VG; Steenwyk BL; Gurley WQ; Pereira SJ; Lell WA; Kirklin JK
    J Heart Lung Transplant; 2006 Jun; 25(6):653-63. PubMed ID: 16730571
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Rationale and design of the PREVENT-HIT study: a randomized, open-label pilot study to compare desirudin and argatroban in patients with suspected heparin-induced thrombocytopenia with or without thrombosis.
    Frame JN; Rice L; Bartholomew JR; Whelton A
    Clin Ther; 2010 Apr; 32(4):626-36. PubMed ID: 20435232
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bivalirudin for the treatment of patients with confirmed or suspected heparin-induced thrombocytopenia.
    Joseph L; Casanegra AI; Dhariwal M; Smith MA; Raju MG; Militello MA; Gomes MP; Gornik HL; Bartholomew JR
    J Thromb Haemost; 2014 Jul; 12(7):1044-53. PubMed ID: 24766902
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Argatroban and bivalirudin compared to unfractionated heparin in preventing thrombus formation on mechanical heart valves. Results of an in-vitro study.
    Maegdefessel L; Linde T; Michel T; Hamilton K; Steinseifer U; Friedrich I; Schubert S; Hauroeder B; Raaz U; Buerke M; Werdan K; Schlitt A
    Thromb Haemost; 2009 Jun; 101(6):1163-9. PubMed ID: 19492162
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treatment of heparin-induced thrombocytopenia: is there a role for bivalirudin?
    Seybert AL; Coons JC; Zerumsky K
    Pharmacotherapy; 2006 Feb; 26(2):229-41. PubMed ID: 16466327
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Heparin-induced thrombocytopenia in the critical care setting: diagnosis and management.
    Napolitano LM; Warkentin TE; Almahameed A; Nasraway SA
    Crit Care Med; 2006 Dec; 34(12):2898-911. PubMed ID: 17075368
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Heparin-induced thrombocytopenia: treatment options and special considerations.
    Dager WE; Dougherty JA; Nguyen PH; Militello MA; Smythe MA
    Pharmacotherapy; 2007 Apr; 27(4):564-87. PubMed ID: 17381384
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Argatroban anticoagulation for heparin induced thrombocytopenia in patients with ventricular assist devices.
    Pappalardo F; Scandroglio AM; Potapov E; Stepanenko A; Maj G; Krabatsch T; Zangrillo A; Koster A; Hetzer R
    Minerva Anestesiol; 2012 Mar; 78(3):330-5. PubMed ID: 22357371
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A randomized, open-label pilot study comparing desirudin and argatroban in patients with suspected heparin-induced thrombocytopenia with or without thrombosis: PREVENT-HIT Study.
    Boyce SW; Bandyk DF; Bartholomew JR; Frame JN; Rice L
    Am J Ther; 2011 Jan; 18(1):14-22. PubMed ID: 21079512
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Argatroban, a new antithrombotic treatment for heparin-induced thrombocytopenia application in cardiac surgery and in intensive care].
    Rozec B; Boissier E; Godier A; Cinotti R; Stephan F; Blanloeil Y
    Ann Fr Anesth Reanim; 2014; 33(9-10):514-23. PubMed ID: 25148720
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacokinetic evaluation of argatroban for the treatment of acute coronary syndrome.
    Cruz-González I; López-Jiménez R; Perez-Rivera A; Yan BP
    Expert Opin Drug Metab Toxicol; 2012 Nov; 8(11):1483-93. PubMed ID: 22970706
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Argatroban Versus Bivalirudin in the Treatment of Suspected or Confirmed Heparin-Induced Thrombocytopenia.
    Duewell BE; Briski MJ; Feih JT; Rinka JRG; Tawil JN
    J Pharm Pract; 2021 Aug; 34(4):529-534. PubMed ID: 31645190
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Direct thrombin inhibitors in the treatment of immune-mediated heparin-induced thrombocytopenia.
    Call JT; Deliargyris EN; Sane DC
    Semin Thromb Hemost; 2004 Jun; 30(3):297-304. PubMed ID: 15282652
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Standardizing the management of heparin-induced thrombocytopenia.
    Fugate S; Chiappe J
    Am J Health Syst Pharm; 2008 Feb; 65(4):334-9. PubMed ID: 18238772
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antithrombotic drugs for the treatment of heparin-induced thrombocytopenia.
    Jeske WP; Walenga JM
    Curr Opin Investig Drugs; 2002 Aug; 3(8):1171-80. PubMed ID: 12211410
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Trends in parenteral direct thrombin inhibitor use in pediatric patients: analysis of a large administrative database.
    Moffett BS; Teruya J
    Arch Pathol Lab Med; 2014 Sep; 138(9):1229-32. PubMed ID: 25171706
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Monitoring of argatroban and lepirudin anticoagulation in critically ill patients by conventional laboratory parameters and rotational thromboelastometry - a prospectively controlled randomized double-blind clinical trial.
    Beiderlinden M; Werner P; Bahlmann A; Kemper J; Brezina T; Schäfer M; Görlinger K; Seidel H; Kienbaum P; Treschan TA
    BMC Anesthesiol; 2018 Feb; 18(1):18. PubMed ID: 29426286
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Heparin-induced thrombocytopenia in intensive care patients.
    Selleng K; Warkentin TE; Greinacher A
    Crit Care Med; 2007 Apr; 35(4):1165-76. PubMed ID: 17334253
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.